About Datavant
Datavant focuses on health data technology, enabling the secure exchange of patient information while preserving privacy. Its main product is software that de-identifies patient health data and links records from different sources, allowing for cohesive data use without revealing personal information. Clients include hospitals, research institutions, and pharmaceutical companies, who rely on Datavant's technology for secure data access essential for research and public health initiatives. The company operates on a subscription-based model, aiming to provide vital tools for secure data sharing and privacy preservation in the healthcare sector.
San Francisco, CaliforniaHeadquarters
2017Year Founded
$78.3MTotal Funding
SERIES_BCompany Stage
Data & Analytics, HealthcareIndustries
5,001-10,000Employees
Benefits
Competitive Salaries & Rewards
Generous Parental & Family Leave
Ability to work anywhere in the US and Canada
Meaningful equity
Competitive Benefits – Full Family Coverage
WFH Stipend & Monthly Credit
Commitment to Learning & Development
Unlimited PTO
Risks
Increased competition from Avandra threatens Datavant's market position.
A recent phishing attack exposed vulnerabilities in Datavant's cybersecurity measures.
Regulatory hurdles in Europe may impact Datavant's expansion with Promptly Health.
Differentiation
Datavant specializes in de-identifying and linking patient health data securely.
The company has a vast network of over 70,000 hospitals and clinics.
Datavant's SaaS model provides customizable solutions for diverse healthcare clients.
Upsides
Growing demand for de-identified data solutions boosts Datavant's market potential.
Partnerships with pharmaceutical companies enhance Datavant's position in clinical research.
Expansion of telehealth services increases need for Datavant's secure data exchange solutions.
Funding
Total raised$78.30 M
Latest valuation$202.50 M
StageSERIES_B
SERIES B
9/30/2020$40
$202.50 MEARLY VC
3/31/2018$40
$202.50 M